Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus

Plastic and Reconstructive Surgery

Volumn 102, Issue 3, 1998, Pages 822-824

  Bentur, Yedidia ^b   Shupak, Avi ^a   Ramon, Yitzchak ^b   Abramovich, Amir ^b   Wolfin, Gershon ^b   Stein, Haim ^b   Krivoi, Norberto ^b  

^a ISRAEL NAVAL MEDICAL INSTITUTE   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; INSULIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; HUMAN; HYPERBARIC OXYGEN; INFECTIOUS COMPLICATION; INSULIN TREATMENT; MUCORMYCOSIS; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT INDICATION;

EID: 0031715665     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199809010-00030     Document Type: Article

References (16)

1. Vainrub, B., Macareno, A., Mandel, S., and Musher, D. M. Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am. J. Med. 84: 546, 1988.
2. Ryan-Poirier, K., Eiseman, R. M., Beaty, J. H., Hunt, P. G., Burghen, G. A., and Leggiadro, R. J. Post-traumatic cutaneous mucormycosis in diabetes mellitus: Shortterm antifungal therapy. Clin. Pediatr. 27: 609, 1988.
3. Adam, R. D., Hunter, G., DiTomassu, J., and Comerci, G., Jr. Mucormycosis: Emerging prominence of cutaneous infections. Clin. Infect. Dis. 19: 67, 1994.
4. Khardori, N., Hayat, S., Rolston, K., and Bodey, G. P. Cutaneous Rhizopus and Aspergillus infections in five patients with cancer. Arch. Dermatol. 125: 952, 1989.
5. Heinz, T., Perfect, J., Schell, W., Ritter, E., Ruff, G., and Serafin, D. Soft-tissue fungal infections: Surgical management of 12 immunocompromised patients. Plast. Reconstr. Surg. 97: 1391, 1996.
6. Salisbury, R. E., Silverstein, P., and Goodwin, M. N., Jr. Upper extremity fungal invasions secondary to large burns. Plast. Reconstr. Surg. 54: 654, 1974.
7. Gartenberg, G., Bottone, E. J., Keusch, G. T., and Weitzman, I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: Epidemiology, mycology and treatment. N. Engl. J. Med. 299: 1115, 1978.
8. Hammond, D. E., and Winkelmann, R. K. Cutaneous phycomycosis: Report of three cases with identification of Rhizopus. Arch. Dermatol. 115: 990, 1979.
9. Ferguson, B. J., Mitchell, T. G., Moon, R., Camporesi, E., M., and Farmer, J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev. Infect. Dis. 10: 551, 1988.
10. Park, M. K., Muhvich, K. H., Myers, R. A. M., and Marzella, L. Effects of Hyperbaric Oxygen in Infectious Diseases: Basic Mechanisms. In E. P. Kindwall (Ed.), Hyperbaric Medicine Practice. Flagstaff. Ariz.: Best Publishing Company, 1995. P. 141.
11. Farmer, J. C., Jr., and Kindwall, E, P. Use of Adjunctive Hyperbaric Oxygen in the Management ot Fungal Disease. In E. P. Kindwall (Ed.), Hyperbaric Medicine Practice. Flagstaff, Ariz.: Best Publishing Company, 1995. P, 581.
12. Gudewiez, T. M., Mader, J. T., and Davis, C. P. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans. Aviat. Space Environ. Med. 58: 673, 1987.
13. Haido, R. M. T., and Barreto-Bergter, E. Amphotericin B-induced damage of Trypanasoma cruzi epirnastigotes. Chem. Biol. Interact. 71: 91, 1989.
14. Sokol-Anderson, M. L., Brajtburg, J., and Medoff, G. Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 154: 76, 1986.
15. Price, J. C., and Stevens, D. L. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 90: 737, 1980.
16. Couch, L., Theilen, F., and Mader, J. T. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch. Otolaryngol. Head Neck Surg. 114: 791, 1988.